Page last updated: 2024-08-17

methylene blue and Retinal Neovascularization

methylene blue has been researched along with Retinal Neovascularization in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Contartese, DS; Dorfman, VB; Fernández, JC; Inserra, PI; Larrayoz, IM; Loidl, CF; López-Costa, JJ; Martínez, A; Martínez-Murillo, R; Rey-Funes, M; Rolón, F1

Other Studies

1 other study(ies) available for methylene blue and Retinal Neovascularization

ArticleYear
Methylene blue prevents retinal damage in an experimental model of ischemic proliferative retinopathy.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2016, 06-01, Volume: 310, Issue:11

    Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Antioxidants; Dose-Response Relationship, Drug; Male; Methylene Blue; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Retinal Neovascularization; Retinopathy of Prematurity; Treatment Outcome

2016